https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42975 Thu 22 Jun 2023 08:51:03 AEST ]]> PSA response signatures: a powerful new prognostic indicator after radiation for prostate cancer? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7230 Sat 24 Mar 2018 08:40:27 AEDT ]]> Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21390 p< 0.001) in urinary dysfunction were measured using the EORTC PR25 instrument at 18 and 36 months. Conclusion: Adjuvant androgen suppression, bisphosphonates and increasing EBRT dose did not increase rectal or urinary dysfunction in this trial. However dose escalation using HDRB increased urinary dysfunction.]]> Sat 24 Mar 2018 08:05:03 AEDT ]]> A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18126 Sat 24 Mar 2018 08:04:29 AEDT ]]> Prostate implant evaluation using tumour control probability: the effect of input parameters https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:3423 Sat 24 Mar 2018 07:21:37 AEDT ]]> Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22823 Sat 24 Mar 2018 07:16:10 AEDT ]]> Theoretical evaluation of a novel method for producing fluorine-18 for Positron-emission-tomography (PET) applications utilizing the 3He(d,p)4He reaction https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48687 Mon 27 Mar 2023 15:56:46 AEDT ]]> Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines: GHG OAR consensus contouring guidance https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44898 Mon 24 Oct 2022 16:10:34 AEDT ]]> Rectal and Urethro-Vesical Subregions for Toxicity Prediction After Prostate Cancer Radiation Therapy: Validation of Voxel-Based Models in an Independent Population https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42286 Fri 17 Nov 2023 11:23:06 AEDT ]]>